TNF and heart failure: Increasing circulating inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1 and IL-6, has been observed in patients with heart failure, which may predict clinical outcomes, but the application of these cytokines is limited by the low circulating volumes and expensive assays (18–21).